CXCL1 and inflammation: Additionally, the concentrations of CXCL-1, a neutrophil chemoattractant, the frequency of CD4+IL-17+ cells and the pulmonary inflammation were increased in the lungs during the comorbidity compared to the WT OVA group (Figure 7D–G).